Anti-Cancer Drug Derived From Himalayan Fungus Clears Early Clinical Trials

+ Retirely on ›

An Oxford University study has shown that the new drug NUC-7738—a novel chemotherapy drug, derived from a fungus—has up to 40 times greater potency for killing cancer cells than its parent compound, with limited toxic side effects. The naturally-occurring nucleoside analogue known as Cordycepin (a.k.a 3’-deoxyadenosine) is found in the Himalayan fungus Cordyceps sinensis and […]

The post Anti-Cancer Drug Derived From Himalayan Fungus Clears Early Clinical Trials appeared first on Good News Network.

The Briefing

Liked this? Get stories like it by email

Top stories, market moves and new columns from our advisors, in one short email.

Confirm by email, unsubscribe in one click. What you'll get

Leave a Reply

Your email address will not be published. Required fields are marked *

AboutTermsPrivacyNewsInvestorsAdvisorsLogin
Dark mode